Citation Formats
Biosimilar infliximab for Behçet's syndrome: a case series.
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

E. Dincses Et Al. , "Biosimilar infliximab for Behçet's syndrome: a case series.," Clinical and experimental rheumatology , no.6, pp.111-115, 2019

Dincses, E. Et Al. 2019. Biosimilar infliximab for Behçet's syndrome: a case series.. Clinical and experimental rheumatology , no.6 , 111-115.

Dincses, E., Esatoglu, S. N., Ozguler, Y., Uygunoglu, U., Hamuryudan, V., Seyahi, E., ... Melikoglu, M.(2019). Biosimilar infliximab for Behçet's syndrome: a case series.. Clinical and experimental rheumatology , no.6, 111-115.

Dincses, E. Et Al. "Biosimilar infliximab for Behçet's syndrome: a case series.," Clinical and experimental rheumatology , no.6, 111-115, 2019

Dincses, E. Et Al. "Biosimilar infliximab for Behçet's syndrome: a case series.." Clinical and experimental rheumatology , no.6, pp.111-115, 2019

Dincses, E. Et Al. (2019) . "Biosimilar infliximab for Behçet's syndrome: a case series.." Clinical and experimental rheumatology , no.6, pp.111-115.

@article{article, author={E. Dincses Et Al. }, title={Biosimilar infliximab for Behçet's syndrome: a case series.}, journal={Clinical and experimental rheumatology}, year=2019, pages={111-115} }